Detection of cancer cells disseminated in bone marrow using real-time quantitative RT-PCR of CEA, CK19, and CK20 mRNA in patients with gastric cancer

被引:61
作者
Fujita Y. [1 ]
Terashima M. [1 ]
Hoshino Y. [1 ]
Ohtani S. [1 ]
Kashimura S. [1 ]
Kanzaki N. [1 ]
Osuka F. [1 ]
Kogure M. [1 ]
Gotoh M. [1 ]
机构
[1] Department of Surgery 1, Fukushima Medical University, Fukushima 960-1295
关键词
Bone marrow; Carcinoembryonic antigen; Cytokeratin; 19; 20; Disseminated cancer cells;
D O I
10.1007/s10120-006-0398-z
中图分类号
学科分类号
摘要
Background. To determine the significance of bone marrow disseminated tumor cells in gastric cancer, we investigated the mRNA expression levels of carcinoembryonic antigen (CEA), cytokeratin 19 (CK19), and cytokeratin 20 (CK20) using the real-time quantitative reverse-transcription polymerase chain reaction (RQ-PCR). Methods. Bone marrow samples were aspirated from the sternum at the time of surgery in 65 patients with resectable gastric cancer. Total RNA was extracted from bone marrow; and the expression levels of CEA, CK19, and CK20 mRNA were determined by RQ-PCR using an ABI PRISM 7000 and quantified against the GAPDH mRNA level. Results. The detection limits of these genes were determined in the gastric cancer cell line MKN-45 and the colon cancer cell line C-1, which had been serially diluted in peripheral blood mononuclear cells (PBMCs). A rate of 1 cancer cell/million PBMCs was obtained by detecting CEA and CK19 mRNA in MKN-45 and by detecting CK20 mRNA in C-1. In the clinical samples, only 1 of the 65 gastric cancer patients (1.5%) who had stage IV disease was positive for CEA, CK19, and CK20 mRNA; none of CEA, CK19, or CK20 mRNA was positive in the remaining 64 patients. No significant correlation was observed between disseminated cancer cells in bone marrow and clinicopathological features, including simultaneous or metachronous hepatic metastasis and patient survival. Conclusion. The incidence of disseminated cancer cells in bone marrow in our study appears low, unlike that in previous reports. The significance of disseminated cancer cells in bone marrow may also be quite low in gastric cancer. © 2006 International and Japanese Gastric Cancer Association.
引用
收藏
页码:308 / 314
页数:6
相关论文
共 25 条
[1]
Kodera Y., Nakanishi H., Ito S., Yamamura Y., Kanemitsu Y., Shimizu Y., Et al., Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: A sensitive predictor of outcome for patients with gastric carcinoma, Ann Surg, 235, pp. 499-506, (2002)
[2]
Oyama K., Terashima M., Takagane A., Maesawa C., Prognostic significance of peritoneal minimal residual disease in gastric cancer detected by reverse transcription-polymerase chain reaction, Br J Surg, 91, pp. 435-43, (2004)
[3]
Funke I., Schraut W., Meta-analyses of studies on bone marrow micrometastases: An independent prognostic impact remains to be substantiated, J Clin Oncol, 16, pp. 557-66, (1998)
[4]
Braun S., Cevatli B.S., Assemi C., Janni W., Kentenich C.R., Schindlbeck C., Et al., Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy, J Clin Oncol, 19, pp. 1468-75, (2001)
[5]
Ozbas S., Dafydd H., Purushotham A.D., Bone marrow micrometastasis in breast cancer, Br J Surg, 90, pp. 290-301, (2003)
[6]
Braun S., Vogl F.D., Naume B., Janni W., Osborne M.P., Coombes R.C., Et al., A pooled analysis of bone marrow micrometastasis in breast cancer, N Engl J Med, 353, pp. 793-802, (2005)
[7]
Lindemann F., Schlimok G., Dirschedl P., Witte J., Riethmuller G., Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients, Lancet, 340, pp. 685-9, (1992)
[8]
Tsavellas G., Patel H., Allen-Mersh T.G., Detection and clinical significance of occult tumour cells in colorectal cancer, Br J Surg, 88, pp. 1307-20, (2001)
[9]
Pantel K., Izbicki J., Passlick B., Angstwurm M., Haussinger K., Thetter O., Et al., Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases, Lancet, 347, pp. 649-53, (1996)
[10]
Osaki T., Oyama T., Gu C.D., Yamashita T., So T., Takenoyama M., Et al., Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer, J Clin Oncol, 20, pp. 2930-6, (2002)